Better CT scans for staging rectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests a new, more detailed type of CT scan (called photon-counting CT) to see if it can better show how far rectal cancer has grown or spread. If you are already getting standard scans to stage your cancer, this study adds an extra CT scan with contrast dye to get clearer pictures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with rectal cancer and your tumor is at least 2 cm (about the size of a grape).
- You are already scheduled for a pelvic MRI and a CT scan of your abdomen and pelvis to check for cancer spread.
- You do not have serious kidney problems (eGFR greater than 60).
- You have never had a moderate or severe allergic reaction to contrast dye.
- You do not have both hip replacements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special scan called PET-MRI can better show how rectal cancer responds to treatment given before surgery. If it works well, it could help doctors plan the right next steps after chemoradiotherapy.
This trial uses advanced MRI scans to see how well rectal cancer is responding to radiotherapy. It may help doctors better understand which treatments work best for patients with more advanced disease.
This trial tests a new type of CT scanner (photon counting CT) to see if it can better find liver spread from colorectal cancer. If you have colorectal cancer and need a liver check, this might help improve detection.
This study uses PET/MRI scans to look at rectal cancer in detail. It may help doctors plan treatment more accurately. The study is for people with stage 2-3 rectal cancer who will get chemotherapy and radiation before surgery.
This trial uses a special CT scanner to get clearer images of colorectal cancer before treatment, which may help doctors more accurately determine how far the cancer has spread. The goal is to plan the most effective treatment.
This Phase 1 study tests a radiation treatment approach guided by MRI scans to help keep nearby organs functioning while treating rectal cancer. It is designed to find a safe, effective way to target the tumor and adjust treatment during the course of therapy.
Hear when a new Rectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.